These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30294247)

  • 1. Role of aberrant glycosylation enzymes in oral cancer progression.
    Vajaria BN; Patel KA; Patel PS
    J Carcinog; 2018; 17():5. PubMed ID: 30294247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary glyco-sialylation changes monitors oral carcinogenesis.
    Vajaria BN; Patel KR; Begum R; Patel JB; Shah FD; Joshi GM; Patel PS
    Glycoconj J; 2014 Dec; 31(9):649-59. PubMed ID: 25318700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
    Shah M; Telang S; Raval G; Shah P; Patel PS
    Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum and salivary total sialic acid and α-l-fucosidase in patients with oral precancerous conditions and oral cancer.
    Vajaria BN; Patel KR; Begum R; Shah FD; Patel JB; Shukla SN; Patel PS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jun; 115(6):764-71. PubMed ID: 23570662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-L-fucosidase levels in patients with oral submucous fibrosis and controls: A comparative study.
    Suresh H; Gunasekaran N; James A; Krishnan R; Thayalan DK; Kumar AR
    J Oral Maxillofac Pathol; 2022; 26(4):594. PubMed ID: 37082061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Aberrant sialylation plays a significant role in oral squamous cell carcinoma progression".
    Mehta KA; Patel KA; Pandya SJ; Patel PS
    J Oral Pathol Med; 2020 Mar; 49(3):253-259. PubMed ID: 31747460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer.
    Raval GN; Patel DD; Parekh LJ; Patel JB; Shah MH; Patel PS
    Oral Dis; 2003 May; 9(3):119-28. PubMed ID: 12945593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis.
    Shah MH; Telang SD; Shah PM; Patel PS
    Glycoconj J; 2008 Apr; 25(3):279-90. PubMed ID: 18158621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum α-l-fucosidase activities are significantly increased in patients with preeclampsia.
    Zhang M; Wang L; Zhang H; Cong J; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():349-362. PubMed ID: 30905462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucosyltransferase and alpha-L-fucosidase activities and fucose levels in normal and malignant endometrial tissue.
    Wang JW; Ambros RA; Weber PB; Rosano TG
    Cancer Res; 1995 Aug; 55(16):3654-8. PubMed ID: 7627975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer.
    Ayude D; Fernández-Rodríguez J; Rodríguez-Berrocal FJ; Martínez-Zorzano VS; de Carlos A; Gil E; Páez de La Cadena M
    Oncology; 2000 Nov; 59(4):310-6. PubMed ID: 11096343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo alterations of enzymatic glycosylation in diabetes.
    Rellier N; Ruggiero-Lopez D; Lecomte M; Lagarde M; Wiernsperger N
    Life Sci; 1999; 64(17):1571-83. PubMed ID: 10353622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of salivary alpha-L-fucosidase and salic acid among oral sub-mucous fibrosis patients.
    Mitra S; Gujjarlapudi S; Abdul NS; Singh P; Giri D; Pansheriya E; Makkad RS
    Bioinformation; 2024; 20(6):669-673. PubMed ID: 39131533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of an allele for low activity of alpha-L-fucosidase in sera: possible increase in epithelial ovarian cancer patients.
    Barlow JJ; DiCioccio RA; Dillard PH; Blumenson LE; Matta KL
    J Natl Cancer Inst; 1981 Nov; 67(5):1005-9. PubMed ID: 6946242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of alpha-L-fucosidase activity in colorectal cancer are due to decreased amounts of the enzymatic protein and are related with Dukes' stage.
    Delacadena M; Fernandez J; Decarlos A; Martinezzorzano V; Gilmartin E; Rodriguezberrocal F
    Int J Oncol; 1996 Oct; 9(4):747-54. PubMed ID: 21541579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors.
    Abdel-Aleem H; Ahmed A; Sabra AM; Zakhari M; Soliman M; Hamed H
    Int J Gynaecol Obstet; 1996 Dec; 55(3):273-9. PubMed ID: 9003953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum alpha-L-fucosidase.
    Alhadeff JA; Janowsky AJ
    Clin Chim Acta; 1978 Jan; 82(1-2):133-40. PubMed ID: 618676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
    Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
    Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum beta-N-acetylglucosaminidase, beta-D-glucosidase, alpha-D-glucosidase, beta-D-fucosidase, alpha-L-fucosidase and beta-D-galactosidase levels in acute viral hepatitis, pancreatitis, myocardial infarction and breast cancer.
    Calvo P; Barba JL; Cabezas JA
    Clin Chim Acta; 1982 Feb; 119(1-2):15-9. PubMed ID: 6800674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of α-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface.
    Cheng TC; Tu SH; Chen LC; Chen MY; Chen WY; Lin YK; Ho CT; Lin SY; Wu CH; Ho YS
    Oncotarget; 2015 Aug; 6(25):21283-300. PubMed ID: 26204487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.